OptimizeRx to Participate in Upcoming September Conferences
ROCHESTER, Mich., Sept. 07, 2022 (GLOBE NEWSWIRE) -- . (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy, announced today that management will participate in the following September conferences on the following days:
- R.W. Baird Healthcare Conference, New York City, September 13
- Lake Street BIG6 Investor Conference, New York City, September 14
- LifeSci Health Tech Symposium, Virtual, September 21
Conference Details:
| R.W. Baird Healthcare Conference Presentation: | |
| Date: | Tuesday, September 13 |
| Time: | 10:15 AM ET |
Management will also be available for in-person one-on-one meetings. To request a meeting or for more details about the conference please reach out to your institutional contact or email: .
| Lake Street BIG6 Investor Conference: | |
| Date: | Wednesday, September 14 |
| Format: | 1-x-1 Meetings |
For more details about the conference or to request an in-person one-on-one meeting please contact: or .
| LifeSci Health Tech Symposium Presentation: | |
| Date: | Wednesday, September 21 |
| Time: | 10:00 AM ET |
For more information about the event or request a virtual meeting please .
About OptimizeRx
OptimizeRx provides best-in-class health technology that enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through the most intelligent technology platform embedded within a proprietary digital point-of-care network, OptimizeRx helps patients start and stay on their medications.
For more information, follow the company on , or visit .
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify these forward-looking statements. All statements that reflect the Company’s expectations, assumptions, projections, beliefs or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Company’s growth, business plans and future performance. These forward-looking statements are based on the Company’s current expectations and assumptions regarding the Company’s business, the economy, and other future conditions. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other risks summarized in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, its subsequent Quarterly Reports on Form 10-Q, and its other filings with the Securities and Exchange Commission.
OptimizeRx Contact
Andy D’Silva, SVP Corporate Finance
Media Relations Contact
Kimberley Sirk
Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC
